New development of epigenome drug discovery to realize oncogene selectivity
Project/Area Number |
16K15592
|
Research Category |
Grant-in-Aid for Challenging Exploratory Research
|
Allocation Type | Multi-year Fund |
Research Field |
General surgery
|
Research Institution | Osaka University |
Principal Investigator |
SATOH Taroh 大阪大学, 医学系研究科, 寄附講座教授 (40368303)
|
Co-Investigator(Kenkyū-buntansha) |
西田 尚弘 大阪大学, 医学系研究科, 助教 (50588118)
今野 雅允 大阪大学, 医学系研究科, 寄附講座講師 (80618207)
川本 弘一 大阪大学, 医学部附属病院, その他 (30432470)
小関 準 大阪大学, 医学系研究科, 特任助教(常勤) (20616669)
工藤 敏啓 大阪大学, 医学系研究科, 寄附講座助教 (20593859)
坂井 大介 大阪大学, 医学系研究科, 寄附講座助教 (10621071)
|
Co-Investigator(Renkei-kenkyūsha) |
ISHII Hideshi 大阪大学, 大学院医学系研究科, 特任教授 (10280736)
MORI Masaki 大阪大学, 大学院医学系研究科, 教授 (70190999)
|
Project Period (FY) |
2016-04-01 – 2018-03-31
|
Project Status |
Completed (Fiscal Year 2017)
|
Budget Amount *help |
¥3,510,000 (Direct Cost: ¥2,700,000、Indirect Cost: ¥810,000)
Fiscal Year 2017: ¥1,430,000 (Direct Cost: ¥1,100,000、Indirect Cost: ¥330,000)
Fiscal Year 2016: ¥2,080,000 (Direct Cost: ¥1,600,000、Indirect Cost: ¥480,000)
|
Keywords | 癌 / 酵素 |
Outline of Final Research Achievements |
To target an oncogene in clinical setting, it is important to develop effective drug discovery based on the accurate information in epigenome. In the present study, the histone demethylating enzyme controlled by oncogene c - MYC was identified as a target candidate by using the comprehensive transcriptome analysis method. As a result, it was shown that histone methylation modification system was important and that NO66 played an important role in gastrointestinal cancer as its target. Furthermore we showed that it was possible to overcome refractory cancer by drug discovery targeting MYC - NO 66, for which we constructed the foundation.
|
Report
(3 results)
Research Products
(15 results)
-
-
-
-
-
-
-
-
-
[Journal Article] Clinical significance of histone demethylase NO66 in invasive colorectal cancer.2017
Author(s)
Nishizawa, Y., Nishida, N., Konno, M., Kawamoto, K., Asai, A., Koseki, J., Takahashi, H., Haraguchi, N., Nishimura, J., Hata, T., Matsuda, C., Mizushima, T., Satoh, T., Doki, Y., Mori, M., Ishii, H.
-
Journal Title
Ann. Surg. Oncol.
Volume: 24
Issue: 3
Pages: 841-849
DOI
Related Report
Peer Reviewed / Open Access
-
[Journal Article] Oncometabolite D-2-hydroxyglurate directly induces epithelial-mesenchymal transition and is associated with distant metastasis in colorectal cancer.2016
Author(s)
Colvin, S. H., Nishida, N., Konno, M., Haraguchi, N., Takahashi, H., Nishimura, J., Hata, T., Kawamoto, K. Asai, A., Tsunekuni, K., Koseki, J., Mizushima, T., Satoh, T., Doki, Y., Mori, M., Ishii, H.
-
Journal Title
Sci. Rep
Volume: 6
Issue: 1
Pages: 36289-36289
DOI
Related Report
Peer Reviewed / Open Access / Int'l Joint Research
-
[Journal Article] Impact of capecitabine and S-1 on anticoagulant activity of warfarin in patients with gastrointestinal cancer.2016
Author(s)
Hata, T., Kudo, T., Sakai, D., Takahashi, H., Haraguchi, N., Nishimura, J., Hata, T., Mizushima, T., Yamamoto, H., Doki, Y., Mori, M., Satoh, T.
-
Journal Title
Cancer Chemother Pharmacol.
Volume: 78
Issue: 2
Pages: 389-396
DOI
Related Report
Peer Reviewed / Open Access
-
-
-
-